Navigation Links
President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
Date:4/12/2012

We must react to the sudden structural changes taking place in the Finnish IT sector and in traditional forestry industry. For Finland to succeed new business and service ecosystems must be developed. Bioeconomy has the prerequisites for becoming a successful example of this for Finnish business life. This will, however, require a functioning collaboration network and our own bioeconomy strategy.

On 12 April 2012, during the VTT Bioeconomy Forum Finland event in Helsinki, the President and CEO of VTT opened discussion on bioeconomy strategy and establishing a various partnership networks.

Bioeconomy has all the prerequisites for creating a radical increase in the value of exports and for developing into a new pillar of support for wellbeing in Finland. This will require the making of choices, the taking of risks, and the development and marketing of bioeconomy-based technologies.

According to expert assessment, by 2020 new technological solutions and diversification could, for example, raise Finland's current forest industry production by 6 billion euros (equal to an increase of 22% compared to 2010 level).

Fossil energy and material resources are shrinking, environmental problems are getting worse, and global population growth continues. On a global scale, adjusting to these developments requires radical changes to production methods, to the use of raw materials, and to living habits in general. Bioeconomy provides an answer to many of these challenges, and creates new business.

The forest industry, for example, can expand its current operations into the production of composites, biofuels and biochemicals, and into service businesses. This would also bring about a corresponding growth in sector profitability.

"I believe that Finland, thanks to its competences and raw materials, can become a future leader in bioeconomy, and create success and wellbeing for itself. The task requires a new way of thinking and
'/>"/>

Contact: Erkki KM Leppvuori, President and CEO
erkki.leppavuori@vtt.fi
358-207-224-100
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Entertainment Studios Networks Names Janice Arouh President, Domestic Distribution and Marketing
2. MiMedx Group Announces Launch of EpiFix™ and Hiring of Vice President, Wound Care
3. Finland invests €1.85 million in pan-European infrastructure for biomedical research
4. Finland to get a Center of Water Efficiency Excellence
5. Finland initiates European biomedical research infrastructures construction with $6.7 million for 2011
6. Rethinking who should be considered essential during a pandemic flu outbreak
7. Wetlands expert: China should think outside the flooding box with Three Gorges Dam
8. EPA and USDA should create new initiative to better monitor nutrients
9. Freezing kidney cancer: Hot treatment should be new gold standard for destroying small tumors
10. Report updates guidelines on how much weight women should gain during pregnancy
11. Study suggests obese women should not gain weight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new ... fully hardware encapsulated fingerprint sensor and matching ... is literally off the grid, isolating fingerprint ... within the fingerprint sensor to provide ultimate ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... heart attack, the portions of the heart damaged by a ... ways to avoid this scarring, which can harden the walls ... the body and eventually lead to heart failure. But new ... School of Medicine shows that interrupting this process can weaken ...
... 2011, Stephen Boppart from the University of Illinois ... convened by the Optical Society of America (OSA). The ... Advisory Committee for the Congressional Research and Development Caucus. ... and of bioengineering at Illinois, will be the first ...
... Nairobi, 15 November 2011 Farmer trainers should be ... rather than on their successes in implementing farming techniques, shows ... the World Agroforestry Centre (ICRAF). , In the study by ... shrubs, fast-growing leguminous shrubs for feeding dairy cows, in Kenya ...
Cached Biology News:Scarring a necessary evil to prevent further damage after heart attack 2Boppart presents at Congressional briefing 2Teaching skills key to selection of a successful model farmer 2
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... advanced cell culture products, announces the availability of BI’s line of human mesenchymal ... Industries, these stem cell differentiation media offer a complete system for multipotency evaluation ...
(Date:7/28/2015)... ... 29, 2015 , ... The new Xsample 530 sample changer for vials can be ... liquid viscosities – from less than 12,000 mPas (internal air) up to 36,000 (external air) ... immediately catches the eye about Xsample 530 is its removable magazine, which is easily lifted ...
(Date:7/28/2015)... , July 21, 2015 ... announced the addition of the "Analysis of ... to their offering. Globally, flow cytometry ... immuno-phenotyping, cell proliferation, cancer, and stem cells. But ... applications primarily because of demand from underdeveloped nations ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2
... Majority of Physicians are Most Concerned About Lack of Reimbursement ... from ... Decision Resources, ... leading research and advisory firms for pharmaceutical and,healthcare issues, finds ...
... Wall Street Journal published,an article on October 29th ... Group LLC and featuring quotes from,President and founder ... Use of Transfusions: New Efforts to Recycle Blood ... Risks, is part of the "The Informed Patient",series ...
... 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ... on,endocrine therapy and oncology, today reported that it ... its Phase 2 trial in endometrial,cancer with AEZS-108, ... The decision to enter the second stage of,patient ...
Cached Biology Technology:The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use 2The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use 3Wall Street Journal Highlights Blood Management, Strategic Healthcare Group LLC, and Dr. Timothy Hannon 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5
... Analysis Note: Protein determined by Biuret ... 25 mM Tris-HCl, pH 7.6, 1 mM ... 2 Preparation Unit Definition: One unit ... per minute at pH 9.8 at 37 ...
... Kit measures adenosine triphosphate (ATP) ... a dynamic range. Based on ... measures ATP in bacterial, plant ... concentration range of 10-11 to ...
... series of refrigerated cold traps offers a ... low volatility/aqueous solvents or high volatility solvents. ... vacuum concentrators/centrifugal evaporators. Also used for maintaining ... as used in electron microscopes. Can be ...
... The RVT405DDA Refrigerated Vapor Trap is ... high boiling solvents such as DMSO ... systems. Its constant temperature refrigeration system ... optimum cryopumping conditions for DMSO, while ...
Biology Products: